

Cardiovascular Surgery
Director of Aortic and Endovascular Surgery Programs, Surgical Director of the TAVR Program Temple University Hospital, Associate Professor Department of Surgery (Cardiovascular) Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA
Dr. Grayson Wheatley, a board-certified heart surgeon with specific expertise in aortic surgery. As a passionate medical professional, educator, and patient advocate, my goal is to provide exceptional patient care that incorporates cutting-edge therapies. At the world-renowned Arizona Heart Institute, I completed my Cardiovascular Surgery Fellowship with Dr. Edward B. Diethrich, a pioneer in endovascular aortic treatments. I also completed a 2-year National Institute of Health-sponsored research fellowship at Duke University School of Medicine under the direction of Dr. David Sabiston. After completing my training, I began my career practicing at the Arizona Heart Institute and Hospital for almost ten years. In the years since, I’ve cared for thousands of patients with aortic disease and trained hundreds of medical students, residents, and fellows on the most effective strategies to manage complex aortic problems. To date, I’ve authored over 120 peer-reviewed research publications and authored two books on the subject. I’ve also patented several medical devices for the treatment of aortic disease and worked with numerous medical device companies to advance the field of aortic surgery. Additionally, I’ve served on a number of committees for professional medical societies and presented at numerous medical conferences across the globe. I also offer consulting services for medical device companies and currently serve on the Editorial Board for several Cardiovascular Surgery journals. As you can see, I enjoy contributing my expertise to the field in any way that I can. I wholeheartedly believe that collaboration is crucial to advancing our understanding and treatment of aortic diseases. To that end, I’ve devoted much of my career to educating people about how aortic diseases occur and what we know about treating them. To remain on the cusp of advances in healthcare delivery, I recently completed a Master’s in Health Analytics degree at Duke University’s Fuqua School of Business. In all I do, it’s an honor to live out a mission I adopted from my mentor, Dr. Edward B Diethrich: “To teach. To care. To pioneer.”
Selected publications from PubMed
Multispecialty involvement in the management of type B aortic dissections in the endovascular era-Implications for training cardiothoracic residents.
Muetterties C, Menon R, Moser W, Carroll N, Marulanda K, Choi M, Wheatley GH 3rd
J Card Surg. 2017 May;32(5):296-300 doi: 10.1111/jocs.13133.
Right Axillary Artery Cannulation for Endovascular Repair of an Acute Type A Aortic Dissection.
Muetterties CE, Conklin JH, Moser GW, Wheatley GH 3rd
Innovations (Phila). 2017 Mar/Apr;12(2):140-143 doi: 10.1097/IMI.0000000000000350.
The butterfly effect: From Seldinger technique to endovascular arch repair.
Wheatley GH 3rd
J Thorac Cardiovasc Surg. 2016 Nov;152(5):1307-1308 doi: 10.1016/j.jtcvs.2016.07.007.
Where there's smoke, there's fire: Chimney stent grafts for hybrid repair of the aortic arch.
Wheatley GH 3rd
J Thorac Cardiovasc Surg. 2016 Oct;152(4):1194 doi: 10.1016/j.jtcvs.2016.06.033.
Ascending Aortic Endoballoon Occlusion Feasible Despite Moderately Enlarged Aorta to Facilitate Robotic Mitral Valve Surgery.
Breves SL, Hong I, McCarthy J, Kashem M, Moser GW, Kelley TM Jr, Mills EE, Wheatley GH 3rd, Guy TS
Innovations (Phila). 2016 Sep/Oct;11(5):355-359.

The main subject discussed during this session is the treatment of complex patients, comorbidities, and the impact on hemostasis. When it comes to statistics regarding bleeding situations, we can observe that between 32% and 68% of cases in open surgeries experience complex bleeding effects. Uncontrolled surgical bleeding is associated with high mortality rates and associated complications increase resource utilization. Furthermore, the optimal use of available hemostatic options may lead to significant hospital cost savings when it comes to controlling surgical bleeding. There are also many patient factors that contribute significantly to the increased risk of surgical bleeding due to comorbidities: uncontrolled diabetes, obesity, and cancer are some of the conditions that affect the natural clotting process. Bearing in mind that patients can be on a number of medications, these can also increase the risk of surgical bleeding. Patient medications may lead to surgical bleeding in approximately 10% to 25% of procedures. A sheet with the hospital-related costs is also provided for reference. To summarize, Dr. Grayson Wheatley gives an overview of the types of bleeding and points out the primary and adjunctive methods that are required in different bleeding solutions.
With Johnson & Johnson MedTech
Published
Jul 2022

The main issues discussed are the five stages of surgical bleeding that take place in almost all types of surgeries. As many articles confirm, there are a lot of different options for the assessment and treatment of intraoperative bleeding, and there are many products and methodologies in the marketplace. Ethicon is the first company to conduct quantitative studies in order to identify the optimal use of hemostats. This study has analyzed 450 surgeons as they choose hemostats predominantly based on site and situation. Site factors refer to the anatomical and critical anatomic structures that could be impacted. On the other hand, situation factors take into account the bleeding risk associated with intraoperative and postoperative actions; other factors also include those such as access or tissue surface. Currently, there are five issues that have emerged in relation to bleeding: continuous oozing, problematic, difficult to access, potential re-bleeding risk, and high-pressure vessel bleeding. During the session, many details are given about each type of bleeding. Lastly, there is also a worksheet provided, where the different kinds of bleeding can be identified as well as the main proposed solutions, and how to use them.
With Johnson & Johnson MedTech
Published
Jul 2022

Surgical bleeding can adversely affect patient outcome, hospital costs, and resources. Intraoperative bleeding is a major cause of cases being opened from MIS procedure with challenging and uncontrollable bleeding during surgery associated with high morbidity and mortality rates. As surgeons we must be OR READY!
With Johnson & Johnson MedTech
Published
May 2022
Help your network discover Dr. Grayson Wheatley's clinical expertise.